physiology, immunology
Antiviral Immunotherapy Comes of Age
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 
Immune System Targets Diverse Viruses Using the Same Small Peptide
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
European Research Council Founder, Molecular Biologist Dies
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
Hormone Loss Prevents Obesity and Diabetes in Mice
Hormone Loss Prevents Obesity and Diabetes in Mice
Abby Olena | Nov 6, 2017
Asprosin—involved in a rare disease called neonatal progeroid syndrome—targets neurons to stimulate appetite, and blocking the hormone wards off weight gain in rodents.
Caught in the Act
Caught in the Act
Devika G. Bansal | Nov 1, 2017
Molecular probes for imaging in live animals
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
A Molecule to Treat Obesity?
A Molecule to Treat Obesity?
Ashley P. Taylor | Oct 18, 2017
GDF-15 lowers body weight in mice and primates.
Compound Found in Red Wine Boosts Immune Cell Function
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 
Cancers Relapse by Feeding Off Immune Signals
Cancers Relapse by Feeding Off Immune Signals
Shawna Williams | Oct 16, 2017
In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.